Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs >

PuraMed BioScience, Inc. (PMBSD)

PMBSD RSS Feed
Add PMBSD Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator mick, Tadaaa, rs99, Das88, RastaOzMonstah
Search This Board:
Last Post: 10/20/2014 11:22:24 PM - Followers: 330 - Board type: Free - Posts Today: 0


PuraMed BioScience Develops a Cannabis-based Epilepsy Medication

http://finance.yahoo.com/news/puramed-bioscience-develops-cannabis-based-180000630.html


OTCPINK
PuraMed BioScience, Inc. is a U.S. SEC Registered & Reporting Company
http://www.otcmarkets.com/stock/pmbs/quote

Symbol: PMBS

https://www.puramedbioscience.com/

http://www.lipigesic.com/



Share Structure:
 As Of July 24th, 2014  1.4 Billion Shares as Float (O/S)

As Of July 24th, 2014  4 Billion Shares Authorized (A/S)

40/1 Reverse Split in the Process which per company filings will result in Approximately 37 Million Shares Outstanding and Meet the OTCQB requirements.


http://www.walgreens.com/store/c/lipi-gesic-m-migraine-relief-liquid-8-pack/ID=prod6103495-product?

About the Company

PuraMed was established to capture two unique opportunities. The first is to build a substantial and profitable business, rapidly, beginning with three products developed by its founders: LipiGesic® M (for acute relief of migraine headaches), LipiGesic® H(for acute relief of tension headaches) and PuraMed™ PM (for insomnia). Each of these is effective and addresses a very large OTC consumer market, collectively well over $2 billion in the U.S. Each product will be unique in its class.

The second, longer term, opportunity is to establish a leadership position in the highly fragmented OTC natural and alternative health remedy market by introducing a “new kind of product line.” Our product line will consist of ‘alternative’ remedies for common ailments, marketed to the masses. Most consumers want products that are, first of all, effective and safe. By applying hard science to ‘natural’ products, management believes it is possible to build a line wherein each product delivers better performance with fewer side effects than its chemical counterparts. With effective marketing, these products will be embraced by the majority, many of whom prefer ‘natural’ alternatives, provided there is no need to sacrifice performance or convenience.

PuraMed BioScience has completed a double blind placebo clinical trial for its leading product, LipiGesic® M, a sublingual acute treatment for the relief from migraine headaches, which was published in the top-tier medical journal, Headache. http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01910.x/abstract 
LipiGesic® M has national distribution and is available nationwide in some of the largest chain drug stores in the United States.


CLICK HERE to Read Lipigesic Clinical Trial 2011 Study

 

Products

Feverfew 3X, the main active ingredient in LipiGesic® M (for migraine relief), is an herb that has been recognized for centuries as having a beneficial effect on migraine, menstrual and other headaches. Another active ingredient, Ginger 2X, is anti-inflammatory, specifically suppressing the expression of several mediators felt crucial in migraine pathogenesis.
Read more: http://www.puramedbioscience.com/lipigesic-m/
 

A combination of acetylsalicylic acid (aspirin) and St. John’s Wort delivered utilizing our sublingual gel delivery system can dramatically increase the speed and levels of relief for many tension headache sufferers.
Read more: http://www.puramedbioscience.com/lipigesic-h/
 

Valerian, St. John’s Wort and Chamomile, all ingredients in LipiGesic® PM (for insomnia), have each been clinically demonstrated to promote healthy sleep. 
Read more: http://www.puramedbioscience.com/lipigesic-pm/

 




Where to Buy

LipiGesic M is will be available in CVS and Walgreens pharmacy stores!

New Distributors to be Announced soon!!!

 

 
 

Click Here to Buy Online:

 
 
http://www.calciumsupreme.com/lipigesic

PMBS product are also in stock and available thru the following retailers as of 07/30/2014-also this is not a complete list:
Healthy Grade Supplements 
AeroComp 
Ezpickin 
Itzadeal 
C&KShoppe 
Dynamic Marketing Concepts USA 
Amaday in Paradise 
December Sun Market 
C-C Warehouse


Recent News

   

PuraMed BioScience Develops a Cannabis-based Epilepsy Medication

 

SCHOFIELD, Wis., Aug. 5, 2014 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCPink: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that it plans to begin testing of a new hemp-based epilepsy medication in the fourth quarter of 2014.

"As we looked at the similarities between migraine and epilepsy the treatment path became obvious," saidRussell Mitchell, CEO and Chairman of PuraMed BioScience. "Epilepsy and migraine seem to be triggered by the same coritcal spreading depression (CSD) in the brain; the difference is the rate of reaction. This may be why many migraineurs are prescribed epileptic medications."

According to an article in Seizure, the prevalence of migraine in people who experience epilepsy is 8.4 to 20 percent. In addition to migraine, an estimated 64 percent of epilepsy sufferers also experience seizure-related (ictal) headaches: 20 percent experience headache prior to the seizure (pre-ictal) and 44 percent experience headache after the seizure (post-ictal).

The third most common neurological disorder in the US, epilepsy affects approximately 2.7 million people, with children and older adults being most susceptible. The condition also causes up to 50,000 sudden deaths each year.

Epilepsy affects veterans wounded in combat. According to Citizens United to Cure Epilepsy, approximately 22 percent of the 440,000 military service men and women who experienced traumatic brain injury are expected to develop post-traumatic epilepsy.

"An epilepsy medication is a natural extension to our product line," said Mitchell. "We have developed a formula, now we will begin the setting up the trials. We have been approached by key researchers who have expressed interest in working with us on CBD-based products.

"Standardization is key to creating a quality sublingual formula," said Mitchell. " Sublingual delivery offers the distinct advantages of faster delivery and efficiency while avoiding the "first pass effect" that often degrades oral medications. Our goal is to build medicines that withstand scientific scrutiny and perform well in double-blind, placebo controlled clinical trials. We believe that the efficacy of our formulations will be proven by scientific trials. This type of testing lends credibility to our line of natural medications which often work faster, more effectively, and have fewer side effects than their chemical-based counterparts."

Currently, PuraMed BioScience is rebranding its flagship product, LipiGesic M, as MigraPure.

About MigraPure

MigraPure uses the same sublingual feverfew and ginger formula that was clinically tested as LipiGesic M. The flavor of this homeopathic, all-natural, over-the-counter migraine headache pain relief medication has been enhanced, but the active ingredients that stop disabling migraine pain and associated symptoms quickly, is the same. MigraPure's feverfew and ginger gel is non-drowsy and non-habit forming. MigraPure is not associated with rebound headaches. MigraPure has an excellent safety profile and has no reported drug interactions. 

About PuraMed BioScience, Inc.

PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to rebranding LipiGesic M to MigraPure, PuraMed BioScience plans to launch additional cannabinoid-enhanced, anti-inflammatory, and anxiolytic products as it moves forward in the development of its cannabinoid product line.

Forward-Looking Statements

This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact: 
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO 
715-359-6373
rmitchell@PuramedBioScience.com 
www.PuramedBioScience.com

PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M

 

SCHOFIELD, Wis., July 30, 2014 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCPink:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is rebranding the LipiGesic® M name along with the name's red and yellow logo. The former will be replaced with the trademarked name MigraPure®  going forward. The new name, logo, and color palette of PuraMed's homeopathic, natural migraine pain reliever will be reintroduced into selected segments of the retail marketplace.

"We've been working on this for over a year," saidRussell Mitchell, CEO and Chairman of PuraMed BioScience. "We needed to secure the trademark for the name and create the image before we announced the development of the enhanced formula and our product line extensions. 

"The new name will be easier for people to remember and pronounce," said Mitchell. "We also believe the new look and color of the logo will convey our 'safe' and 'natural' message at a glance. Preliminary feedback about the change has been positive and we are pleased. We will now have packaging that reflects the excellent product inside."

PuraMed hopes to have the new product, which uses a flavor-enhanced version of the sublingual LipiGesic M formula, new packaging, new price point, and a new website ready for public purchase within the next two months, though promotion and distribution to retailers and targeted wholesale partners will begin earlier.

"The manufacturing order has been placed," said Mitchell. "Our marketing plan is being finalized and as soon as the packaging and the website are ready, we will launch."

MigraPure's fresh look and message will replace the red and yellow LipiGesic logo. A tagline that describes the product will also be a fundamental part of the logo.

"By using a tagline with the image, we can make a stronger statement and leave no doubt in the consumer's mind about what MigraPure is or what it does, which is also an improvement," said Mitchell. "During the re-launch, we will also reference LipiGesic M on the packaging and other marketing materials in order to maintain a connection with our clinical trial data and our current customer base."

Development of the gel, packaging, and launch of the website are the first steps in the rebranding effort. PuraMed plans to continue to sell LipiGesic M under the old label until the new product is available.

A version of the new logo can be seen at www.lipigesic.com/MigraPure.

About MigraPure

MigraPure uses the same sublingual feverfew and ginger formula that was clinically tested as LipiGesic M. The flavor of this all-natural, over-the-counter migraine headache pain relief medication has been enhanced, but the active ingredients that stop disabling migraine pain and associated symptoms quickly, are the same. MigraPure's feverfew and ginger gel is non-drowsy and non-habit forming. MigraPure is not associated with rebound headaches. MigraPure has an excellent safety profile and has no reported drug interactions. 

About PuraMed BioScience, Inc.

PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to rebranding LipiGesic M to MigraPure, PuraMed BioScience plans to launch additional cannabinoid-enhanced, anti-inflammatory, and anxiolytic products as it moves forward in the development of its cannabinoid product line.

Forward-Looking Statements

This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact:
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO
715-359-6373
rmitchell@PuramedBioScience.com
www.PuramedBioScience.com

SOURCE PuraMed BioScience, Inc.

Current LipiGesic M videos

  Dr. Cady videoDr. Roger Cady, discusses the results of treatment of migraine headache with fever few and ginger, the active ingredients in the migraine treatment LipiGesic® M.
VIEW NOW
  Sherry TorkosPharmacist Sherry Torkos recommends all-natural, homeopathic LipiGesic® M.
VIEW NOW
  Nutrition and J.J. Virgin fitness expert J.J. Virgin shares how LipiGesic® M has helped her teenage son eliminate migraine pain.
VIEW NOW

 

 


 

 

 
      REBRANDING, TRADEMEARK AND PATENTS ARE NOW COMPLETE 07/30/2014      


 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PMBSD
Current Price
Volume:
Bid Ask Day's Range
Wiki
PMBS News: PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 07/22/2014 08:49:00 AM
PMBS News: PuraMed BioScience Announces Product Donation at a Sponsorship Level to Operation Gratitude 07/08/2014 09:11:00 AM
PMBS News: PuraMed BioScience and Honoring Our Troops Partner Together to Sponsor a PTSD Event 06/11/2014 08:00:00 AM
PostSubject
#16148  Sticky Note 07-11-14/ Report Filing (8-k) Puramed Bioscience, Inc. (PC) mick 07/11/14 09:01:50 PM
#20375   Sorry Brando5, but that statement doesn't make any sense! HHHG 10/20/14 11:22:24 PM
#20374   Yes the r/s went through and the outstanding rs99 10/20/14 09:23:18 PM
#20373   Did the reverse split happen and if so, skyrocketinsight 10/20/14 07:13:44 PM
#20372   Because I know what the downside will be. RookieStockPicker 10/20/14 06:18:00 PM
#20371   Why would you want this at .0002? Lockman 10/20/14 06:11:39 PM
#20370   Looks like bid sitters are making out pretty good. rs99 10/20/14 05:08:48 PM
#20369   Waiting to load at .0002...chance are they will RookieStockPicker 10/20/14 03:55:58 PM
#20368   PuraMed BioScience Nears Completion of a Hemp-Derived-Cannabinoid-Based Non-Pres brando5 10/20/14 03:54:07 PM
#20367   This low will lead to hopefully a great brando5 10/20/14 03:52:39 PM
#20366   This stock is being manipulated. Look at the trades. rs99 10/20/14 02:05:43 PM
#20365   Trips this week, down down down this scam goes Gharet 10/20/14 01:54:48 PM
#20364   Have you really checked out Ludlow? They get rs99 10/20/14 07:02:03 AM
#20363   Ground floor low 100k market cap with big brando5 10/20/14 03:49:29 AM
#20362   http://www.newschannel10.com/story/26797694/ludlow-research-issues-opinion-on-pm brando5 10/19/14 11:39:37 PM
#20361   Lots in works brewing for PMBS. Fluctuations in brando5 10/19/14 11:29:20 PM
#20360   assets worth? mick 10/19/14 09:25:52 PM
#20359   i dunno why ceo said none and there mick 10/19/14 08:01:45 PM
#20358   Yes he did mick, so many ways he rs99 10/19/14 01:50:48 PM
#20357   Yep, he is truly a giant steaming piece Gharet 10/19/14 01:09:28 PM
#20356   ceo doubled crossed all shareholders! mick 10/19/14 01:08:33 PM
#20355   TIMBER!!! LOL!! Russ is definitely a Gharet 10/18/14 07:33:34 PM
#20354   stockcharts.com/c-sc/sc?chart=PMBSD,uu[305,a]dacayaci[pb20!b50][dg][/char mick 10/18/14 05:20:04 PM
#20352   We will have trips next week, Russ took Gharet 10/17/14 05:45:31 PM
#20351   Wow, down she goes. What about it Russ? rs99 10/17/14 03:42:09 PM
#20350   Let the dilution and dumping begin! Won't Gharet 10/17/14 02:39:27 PM
#20349   LOL, wondered why the volume was so low. rs99 10/17/14 12:36:23 PM
#20348   This is happening now: Mongol76 10/17/14 11:36:58 AM
#20347   There could be alotta "dumping"??? That's an UNDERSTATEMENT. XYREUS 10/17/14 11:26:00 AM
#20346   All of this is based on IF they rs99 10/17/14 08:52:29 AM
#20345   There could be a lot of dumping when rs99 10/17/14 08:50:05 AM
#20344   Keep in mind that many affected by the Rocco63 10/17/14 07:52:58 AM
#20343   0044 = breakout trigger sweet crude 10/17/14 07:16:02 AM
#20340   Again, ALL COMPANIES on pinks have that statement brando5 10/17/14 03:20:48 AM
#20339   PMBS definitely gaining attention. Lots brewing. brando5 10/17/14 03:06:26 AM
#20338   Too many things coming and already very undervalued. brando5 10/17/14 03:03:49 AM
#20337   PMBSD is definitely undervalued at under 200k market brando5 10/17/14 02:58:07 AM
#20336   The float is finally tiny. Shark Attack 10/16/14 10:42:42 PM
#20335   It could just rise to .01 too. Shark Attack 10/16/14 04:39:20 PM
#20334   imo this will be hitting mid trips, im apple-bag 10/16/14 04:12:33 PM
#20333   The stock is dirt cheap. Shark Attack 10/16/14 03:48:26 PM
#20332   003 = $210,000 market cap sweet crude 10/16/14 01:48:52 PM
#20330   Read the last filing. It says alot about rs99 10/16/14 11:28:59 AM
#20329   The company has legit PRs that say a brando5 10/16/14 11:19:23 AM
#20328   Just another pathetic attempt at a pump with HHHG 10/16/14 11:09:04 AM
#20327   Yeah, it sure doesn't! rs99 10/16/14 10:54:58 AM
#20326   MOMO comes and PPS move. Talking on IHUB VMAN06 10/16/14 10:19:13 AM
#20325   Sound like someone we know? lol rs99 10/16/14 08:37:41 AM
#20324   Reading the K 10, this company has a rs99 10/16/14 08:35:49 AM
#20323   Wonder how many shares Ludlow Equity Research has? rs99 10/16/14 07:05:50 AM
#20322   He has plenty of that. Almost as much rs99 10/16/14 06:59:20 AM
PostSubject